tiprankstipranks
Trending News
More News >
Alphamab Oncology (HK:9966)
:9966
Hong Kong Market

Alphamab Oncology (9966) Similar Stocks

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Alphamab Oncology
HK$10.91
HK$10.63B
42.78
224.28%
2 Buy
0 Hold
0 Sell
Moderate Buy
Ascletis Pharma, Inc.
HK$13.00
HK$12.99B
-43.89
350.00%
0 Buy
1 Hold
0 Sell
Hold
HBM Holdings Ltd.
HK$13.34
HK$11.78B
17.85
828.87%
0 Buy
0 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$5.43
HK$10.09B
-48.22
82.21%
1 Buy
0 Hold
0 Sell
Moderate Buy
Abbisko Cayman Limited
HK$13.48
HK$9.17B
47.30
205.07%
5 Buy
0 Hold
0 Sell
Strong Buy
SinoMab Bioscience Ltd.
HK$1.48
HK$2.04B
-10.30
40.95%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:9966
Alphamab Oncology
11.22
7.82
230.00%
HK:1672
Ascletis Pharma, Inc.
12.51
9.36
297.14%
HK:2142
HBM Holdings Ltd.
13.19
11.77
828.87%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.43
2.78
104.91%
HK:2256
Abbisko Cayman Limited
13.24
8.88
203.67%
HK:3681
SinoMab Bioscience Ltd.
1.48
0.39
35.78%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts